Developer docs
API playgroundTry for free, no card

Search company profiles

Celleste Bio

Full company profile

uuid0000vvq

Namestring
Celleste Bio
Legal namestring
Celleste Bio Ltd.
Company typeenum
Private
Founded yearint
2022
Descriptiontext

Celleste Bio is an Israeli food biotech company founded in 2022 that produces cocoa butter and cocoa powder through plant cell culture in bioreactors, eliminating dependence on traditional cocoa farming. The company's proprietary cocoa technology uses cell suspension culture to grow cocoa cells from a single bean in 7-10 days, achieving a claimed output of up to one ton of cocoa butter per 1,000-liter bioreactor per year — a process said to replace approximately 1 hectare of cocoa trees, 4 tons of pods, and 1,736 trees per ton. The technology is non-GMO, integrates biotech, agtech, and AI computational modelling to customize melting points and flavor profiles, and produces ingredients that the company reports are bio-identical to traditional cocoa butter in chemical composition, fatty acid profile, texture, melt profile, and sensory qualities.

The company's product portfolio spans two lines: a commodity drop-in replacement line of chocolate-grade cocoa butter and powder, and a tailored/fine-flavor line enabled by AI customization. Celleste operates as a B2B ingredient supplier, targeting large chocolate manufacturers with a go-to-market centered on co-development and pilot partnerships. Its core customer relationship is with Mondelēz International, which has invested through SnackFutures Ventures, served as a strategic and design partner since founding, and manufactured prototype milk chocolate bars using Celleste's cultivated cocoa butter that passed integrity and consumption standards. The company is building a pilot facility in Israel and is targeting commercial volumes exceeding 10,000 liters by 2027.

Celleste has raised approximately $5.6 million to date across two seed rounds (2022 founding round led by Trendlines Group, December 2024 extension led by Supply Change Capital), with backing from Mondelēz, Barrel Ventures, Regba Group, and the BIRD Foundation. The company is supported by a team of approximately 15 scientific and operational staff and an advisory board including senior R&D and agricultural leaders from Mars and Mondelēz. Revenues are not publicly disclosed and the company is pre-commercial, with its pilot facility still under construction.

Short descriptiontext

Celleste Bio is an Israeli food biotech company that produces bio-identical cocoa butter and cocoa powder via plant cell culture in bioreactors, targeting large chocolate manufacturers with a drop-in B2B ingredient supply, anchored by a strategic partnership with Mondelēz International.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMisgav, Israel
HQ citystring
Misgav
HQ countrystring
Israel
HQ regionstring
Middle East
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cell-cultured cocoa ingredients, plant cell culture technology, cultured cocoa butter, bioreactor food production, cellular agriculture biotechnology
Industry2 codes
PRIMARYAFAKAAAD
Confectionery Manufacturing (Chocolate, Candy, Gum)
SECONDARYAFAKADAK
Chocolate, Sweet Spreads & Syrups Manufacturing
Agriculture & Food Production/Food Processing & Manufacturing/Condiments, Sauces, Dressings & Spreads Manufacturing
NAICS code2 codes
  • Sugar and Confectionery Product Manufacturing3113
  • Chocolate and Confectionery Manufacturing from Cacao Beans311351
SIC code2 codes
  • Sugar & Confectionery Products2060
  • Food And Kindred Products2000
Product category
Cultured Cocoa Ingredients
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Cocoa Ingredient Sales
TypeOne Time License
Description

Celleste Bio produces and sells cell-cultured cocoa butter and cocoa powder as drop-in replacement ingredients for chocolate manufacturers. The company positions its products as commodity alternatives to traditionally-sourced cocoa ingredients, targeting the $16.5 billion annual chocolate industry cocoa ingredient spend ($7 billion specifically for cocoa butter). Products are sold directly to chocolate manufacturers as B2B ingredients.

celleste-bio.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Personnel, Operations, Infrastructure, Supply Chain, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Celleste Bio produces and sells cell-cultured cocoa butter and cocoa powder as commodity drop-in replacement ingredients for chocolate manufacturers, manufactured through proprietary plant cell suspension culture in bioreactors rather than traditional cocoa farming. The company also offers tailored cocoa ingredients with customized sweetness, melting temperatures and fine flavors, enabled by AI computational modelling, to industrial confectionery customers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 400% cocoa price increase in 2024 due to global shortage of 500,000 tons
+3 more records
Product overview1 text field

Celleste Bio is a cocoa-technology company that produces 100% real cocoa ingredients through proprietary plant cell culture technology. The company operates a dual product portfolio: (1) Chocolate grade cocoa butter and cocoa powder as commodity drop-in replacements that seamlessly integrate into existing chocolate manufacturing processes, and (2) Tailored products and fine flavors offering customizable sweetness levels, melting temperatures, and unique flavor profiles enabled by AI computational modelling. The technology uses one cocoa bean to grow cocoa cells in bioreactors, producing bio-identical cocoa ingredients in 7-10 days without genetic modification, addressing the industry's supply chain volatility, climate vulnerability, and sustainability challenges.

Product and service2 records
1Chocolate-Grade Cocoa Butter (Cell-Cultured)
CategoryCell-cultured cocoa ingredients
2Cocoa Powder (Cell-Cultured)
Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-12-27
Description

The Cultured Hub, a Swiss biotech facility established by Bühler Group, Migros, and Givaudan, has expanded services to include plant cell culture technology for producing cocoa, coffee, and citrus ingredients. Celleste Bio presented at the Cultured Plant Cell Event hosted by the hub, fostering collaboration between startups and industry leaders.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-10-15
Description

EIT Food is a European innovation community supporting food system transformation. Celleste Bio announced its first chocolate-grade cocoa butter milestone at EIT Food's Next Bite Summit in Brussels, positioning Celleste within the European food tech ecosystem.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-12-05
Description

Mondelēz International serves as strategic and design partner for Celleste Bio. SnackFutures Ventures, Mondelēz's VC arm, invested $4.5 million in Celleste Bio's seed funding round led by Supply Change Capital. Mondelēz previously invested in Celleste in 2022. The partnership involves co-development of cell-cultured cocoa butter, with Mondelēz manufacturing prototype chocolate bars using Celleste's cultivated cocoa butter ingredients.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Direct cell-cultured cocoa competitor using plant cell culture technology to produce cocoa ingredients without traditional farming. Most directly comparable to Celleste Bio in both technology approach and target market.

TypeDirect peer
Description

Cell-culture platform company developing coffee and cocoa ingredients via plant cell culture. Operates in the same technology category and addresses the same target market of chocolate and beverage manufacturers seeking supply alternatives.

TypeEmerging player
Description

Alternative chocolate and coffee company producing bean-free chocolate from upcycled ingredients. Adjacent approach to cocoa supply problem but uses fermentation rather than cell culture, competing for the same chocolate manufacturer customer base.

TypeBroad incumbent
Description

World's largest chocolate and cocoa manufacturer, sourcing cocoa beans and processing them into industrial chocolate and cocoa ingredients. Major incumbent customer and potential competitor in the alternative cocoa space.

TypeBroad incumbent
Description

Global agribusiness with major cocoa processing operations, supplying cocoa butter and powder to chocolate manufacturers. Established incumbent whose customer base overlaps with Celleste's target market.

TypeBroad incumbent
Description

Cell-culture food technology company producing cell-cultured dairy proteins. Comparable in biotechnology platform approach and cellular agriculture category, though applied to dairy rather than cocoa.

TypeBroad incumbent
Description

Cell-culture food technology company producing animal-free proteins via precision fermentation and cellular agriculture. Comparable in biotech platform approach and scaling challenges of cell-culture food ingredients.

TypeEmerging player
Description

Cocoa processing technology company developing alternative methods for cocoa ingredient production. Adjacent to Celleste's value chain though approach differs from cell culture.

TypeBroad incumbent
Description

Cell-culture ingredient company producing animal-free proteins via fermentation. Comparable in cellular agriculture platform approach and B2B ingredient supply model to food and beverage manufacturers.

TypeBroad incumbent
Description

Cell-culture dairy company producing animal-free milk proteins via precision fermentation. Comparable in biotech platform approach, regulatory navigation challenges, and B2B ingredient supply to food manufacturers.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles13 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors7 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Celleste Bio

Cultured Cocoa Ingredientscelleste-bio.com

Celleste Bio is an Israeli food biotech company that produces bio-identical cocoa butter and cocoa powder via plant cell culture in bioreactors, targeting large chocolate manufacturers with a drop-in B2B ingredient supply, anchored by a strategic partnership with Mondelēz International.

What Celleste Bio does

Celleste Bio is an Israeli food biotech company founded in 2022 that produces cocoa butter and cocoa powder through plant cell culture in bioreactors, eliminating dependence on traditional cocoa farming. The company's proprietary cocoa technology uses cell suspension culture to grow cocoa cells from a single bean in 7-10 days, achieving a claimed output of up to one ton of cocoa butter per 1,000-liter bioreactor per year — a process said to replace approximately 1 hectare of cocoa trees, 4 tons of pods, and 1,736 trees per ton. The technology is non-GMO, integrates biotech, agtech, and AI computational modelling to customize melting points and flavor profiles, and produces ingredients that the company reports are bio-identical to traditional cocoa butter in chemical composition, fatty acid profile, texture, melt profile, and sensory qualities.

The company's product portfolio spans two lines: a commodity drop-in replacement line of chocolate-grade cocoa butter and powder, and a tailored/fine-flavor line enabled by AI customization. Celleste operates as a B2B ingredient supplier, targeting large chocolate manufacturers with a go-to-market centered on co-development and pilot partnerships. Its core customer relationship is with Mondelēz International, which has invested through SnackFutures Ventures, served as a strategic and design partner since founding, and manufactured prototype milk chocolate bars using Celleste's cultivated cocoa butter that passed integrity and consumption standards. The company is building a pilot facility in Israel and is targeting commercial volumes exceeding 10,000 liters by 2027.

Celleste has raised approximately $5.6 million to date across two seed rounds (2022 founding round led by Trendlines Group, December 2024 extension led by Supply Change Capital), with backing from Mondelēz, Barrel Ventures, Regba Group, and the BIRD Foundation. The company is supported by a team of approximately 15 scientific and operational staff and an advisory board including senior R&D and agricultural leaders from Mars and Mondelēz. Revenues are not publicly disclosed and the company is pre-commercial, with its pilot facility still under construction.

Celleste Bio firmographics

Firmographics
Name
Celleste Bio
Legal name
Celleste Bio Ltd.
Website
https://celleste-bio.com
Company type
Private
Founded year
2022
Operating status
Operating
Headcount range
11–50 employees
Short description
Celleste Bio is an Israeli food biotech company that produces bio-identical cocoa butter and cocoa powder via plant cell culture in bioreactors, targeting large chocolate manufacturers with a drop-in B2B ingredient supply, anchored by a strategic partnership with Mondelēz International.
Ownership category
akta.pro rank

Celleste Bio industry classification

Industry
Product category
Cultured Cocoa Ingredients
NAICS
Sugar and Confectionery Product Manufacturing (3113), Chocolate and Confectionery Manufacturing from Cacao Beans (311351)
SIC
Sugar & Confectionery Products (2060), Food And Kindred Products (2000)
akta.pro industry
PRIMARYAFAKAAAD
Confectionery Manufacturing (Chocolate, Candy, Gum)
SECONDARYAFAKADAK
Chocolate, Sweet Spreads & Syrups Manufacturing
Agriculture & Food Production/Food Processing & Manufacturing/Condiments, Sauces, Dressings & Spreads Manufacturing

Keywords

  • Cell-cultured cocoa ingredients
  • Plant cell culture technology
  • Cultured cocoa butter
  • Bioreactor food production
  • Cellular agriculture biotechnology

Where Celleste Bio is headquartered

Location

Headquarters

HQ city
Misgav
HQ country
Israel
HQ region
Middle East

Offices1 record

Markets served

Celleste Bio business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations, Infrastructure, Supply Chain, Marketing or Sales

Revenue model

  1. Cocoa Ingredient Sales: Celleste Bio produces and sells cell-cultured cocoa butter and cocoa powder as drop-in replacement ingredients for chocolate manufacturers. The company positions its products as commodity alternatives to traditionally-sourced cocoa ingredients, targeting the $16.5 billion annual chocolate industry cocoa ingredient spend ($7 billion specifically for cocoa butter). Products are sold directly to chocolate manufacturers as B2B ingredients.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Celleste Bio product offering

Product offering

Core offering

Celleste Bio produces and sells cell-cultured cocoa butter and cocoa powder as commodity drop-in replacement ingredients for chocolate manufacturers, manufactured through proprietary plant cell suspension culture in bioreactors rather than traditional cocoa farming. The company also offers tailored cocoa ingredients with customized sweetness, melting temperatures and fine flavors, enabled by AI computational modelling, to industrial confectionery customers.

Product overview

Celleste Bio is a cocoa-technology company that produces 100% real cocoa ingredients through proprietary plant cell culture technology. The company operates a dual product portfolio: (1) Chocolate grade cocoa butter and cocoa powder as commodity drop-in replacements that seamlessly integrate into existing chocolate manufacturing processes, and (2) Tailored products and fine flavors offering customizable sweetness levels, melting temperatures, and unique flavor profiles enabled by AI computational modelling. The technology uses one cocoa bean to grow cocoa cells in bioreactors, producing bio-identical cocoa ingredients in 7-10 days without genetic modification, addressing the industry's supply chain volatility, climate vulnerability, and sustainability challenges.

Differentiator

Problem solved

Functional benefit

Products and services

  • Chocolate-Grade Cocoa Butter (Cell-Cultured)
  • Cocoa Powder (Cell-Cultured)

Quantifiable outcome

  • 400% cocoa price increase in 2024 due to global shortage of 500,000 tons
  • +3 more outcomes

Companies that use Celleste Bio

Customer profile

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Celleste Bio technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature3 records

Celleste Bio partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered minor and core.

  • The Cultured HubminorStrategic or Co-development Partner · 27 December 2025The Cultured Hub, a Swiss biotech facility established by Bühler Group, Migros, and Givaudan, has expanded services to include plant cell culture technology for producing cocoa, coffee, and citrus ingredients. Celleste Bio presented at the Cultured Plant Cell Event hosted by the hub, fostering collaboration between startups and industry leaders.
  • EIT FoodminorStrategic or Co-development Partner · 15 October 2025EIT Food is a European innovation community supporting food system transformation. Celleste Bio announced its first chocolate-grade cocoa butter milestone at EIT Food's Next Bite Summit in Brussels, positioning Celleste within the European food tech ecosystem.
  • Mondelēz InternationalcoreStrategic or Co-development Partner · 5 December 2024Mondelēz International serves as strategic and design partner for Celleste Bio. SnackFutures Ventures, Mondelēz's VC arm, invested $4.5 million in Celleste Bio's seed funding round led by Supply Change Capital. Mondelēz previously invested in Celleste in 2022. The partnership involves co-development of cell-cultured cocoa butter, with Mondelēz manufacturing prototype chocolate bars using Celleste's cultivated cocoa butter ingredients.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Celleste Bio competitors and assessment

Company assessment

Direct peers

  • California Cultured: Direct cell-cultured cocoa competitor using plant cell culture technology to produce cocoa ingredients without traditional farming. Most directly comparable to Celleste Bio in both technology approach and target market.
  • FoodBrewer: Cell-culture platform company developing coffee and cocoa ingredients via plant cell culture. Operates in the same technology category and addresses the same target market of chocolate and beverage manufacturers seeking supply alternatives.

Emerging players

  • Voyage Foods: Alternative chocolate and coffee company producing bean-free chocolate from upcycled ingredients. Adjacent approach to cocoa supply problem but uses fermentation rather than cell culture, competing for the same chocolate manufacturer customer base.
  • CacaoLAT: Cocoa processing technology company developing alternative methods for cocoa ingredient production. Adjacent to Celleste's value chain though approach differs from cell culture.

Broad incumbents

  • Barry Callebaut: World's largest chocolate and cocoa manufacturer, sourcing cocoa beans and processing them into industrial chocolate and cocoa ingredients. Major incumbent customer and potential competitor in the alternative cocoa space.
  • Cargill: Global agribusiness with major cocoa processing operations, supplying cocoa butter and powder to chocolate manufacturers. Established incumbent whose customer base overlaps with Celleste's target market.
  • Perfect Day: Cell-culture food technology company producing cell-cultured dairy proteins. Comparable in biotechnology platform approach and cellular agriculture category, though applied to dairy rather than cocoa.
  • The EVERY Company (formerly Clara Foods): Cell-culture food technology company producing animal-free proteins via precision fermentation and cellular agriculture. Comparable in biotech platform approach and scaling challenges of cell-culture food ingredients.
  • Geltor: Cell-culture ingredient company producing animal-free proteins via fermentation. Comparable in cellular agriculture platform approach and B2B ingredient supply model to food and beverage manufacturers.
  • Remilk: Cell-culture dairy company producing animal-free milk proteins via precision fermentation. Comparable in biotech platform approach, regulatory navigation challenges, and B2B ingredient supply to food manufacturers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Celleste Bio financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Celleste Bio leadership team

Management profile

Number of profiles

Profiles13 records

Celleste Bio funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Celleste Bio M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Celleste Bio

What does Celleste Bio do?

Celleste Bio produces and sells cell-cultured cocoa butter and cocoa powder as commodity drop-in replacement ingredients for chocolate manufacturers, manufactured through proprietary plant cell suspension culture in bioreactors rather than traditional cocoa farming. The company also offers tailored cocoa ingredients with customized sweetness, melting temperatures and fine flavors, enabled by AI computational modelling, to industrial confectionery customers.

Is Celleste Bio a public or private company?

Celleste Bio is a private company. It is classified as venture growth investor backed and is currently operating.

When was Celleste Bio founded?

Celleste Bio was founded in 2022. It employs 11 to 50 people.

Where is Celleste Bio based?

Celleste Bio is headquartered in Misgav, Israel, in the Middle East region.

How does Celleste Bio make money?

One revenue line is on record: cocoa Ingredient Sales.

Who are Celleste Bio's main competitors?

Direct peers on record are California Cultured and FoodBrewer. Emerging players are Voyage Foods and CacaoLAT. Broad incumbents are Barry Callebaut, Cargill, Perfect Day, The EVERY Company (formerly Clara Foods), Geltor and Remilk.

Does Celleste Bio have an API?

No public API is recorded for Celleste Bio.

What industry is Celleste Bio in?

Celleste Bio's product category is Cultured Cocoa Ingredients. Its primary akta.pro industry code is AFAKAAAD, Confectionery Manufacturing (Chocolate, Candy, Gum), with a secondary code of AFAKADAK, Chocolate, Sweet Spreads & Syrups Manufacturing. Its NAICS code is 3113 and its SIC code is 2060.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Supply Chain DiveChocolate makers rethink supply chains in face of cocoa price swingsCocoa prices surged to a record $10.7 per kilogram in January 2025 due to extreme climate conditions in West Africa, then plummeted to $3.24 in March 2026 before recovering to $4.36 in June, driven by favorable weather in Côte d'Ivoire and Ghana which together produce about 60% of global cocoa. Chocolate manufacturers Mondelēz International and Hershey are reorganizing supply chains, diversifying sourcing, and cutting costs to guard against future price volatility, with Mondelēz even producing cell-cultured chocolate through a partnership with startup Celleste Bio. The World Bank warns that prices could face fresh shocks from a stronger-than-expected El Niño weather pattern.foodnavigator.comInside Big Chocolate’s Cocoa Plan BMajor confectionery companies including Mars, Nestlé, Lindt & Sprüngli, Barry Callebaut, and Mondelēz International are actively developing and commercializing cocoa alternatives in response to record-high cocoa prices and supply chain volatility. These companies have launched cocoa-free products using ingredients like ChoViva (from Planet A Foods), invested in cultivated cocoa technologies through Celleste Bio and Food Brewer, and established strategic partnerships to scale alternative cocoa globally. Industry leaders are positioning these alternatives not as replacements for conventional cocoa but as additional tools to improve supply chain resilience and hedge against future price shocks and climate-related disruptions.FoodinspirationSpotted: five promising high-tech food startups at HackSummit in SwitzerlandAt the HackSummit in Lausanne, Switzerland, five high-tech food startups were highlighted for their commercial potential, scalability, and problem-solving capabilities, as investment in the broader food tech sector has fallen 72% from its 2021 peak. The featured startups — Celleste Bio (cultivated cocoa via cellular agriculture), Kioga (functional microbiome ingredients), Ārepa (neuroactive ingredients from blackcurrants), MATR Foods (fermentation-based plant proteins), and GAYA Earth (mushroom-based functional cacao) — represent a shift in the sector away from disruptive hype toward concrete solutions addressing supply chain resilience, mental health, and clean-label nutrition. The article identifies three emerging trends: climate-resilient supply chains, food for mental performance and longevity, and fermentation-powered clean-label innovation.OfimagazineCelleste Bio launches first milk chocolate bars made with…Israeli food biotech company Celleste Bio has partnered with US confectionery giant Mondelēz International to produce milk chocolate bars made with cell-cultured cocoa butter, following Celleste's launch of the ingredient in October. Mondelēz manufactured about a dozen prototype bars using the cell-cultured cocoa butter, which passed integrity and consumption standards, demonstrating that the cultivated butter functions identically to traditional cocoa butter in texture, melt profile, and sensory experience. Celleste plans to scale up production to reach market-ready quantities within the next two years and is using AI computational modelling to customize melting points and taste profiles for specific customer demands.foodnavigator.comFrom Nestlé to Mondelēz, alt chocolate is gaining real groundAlternative cocoa ingredients are gaining momentum in the chocolate industry amid a deepening cocoa crisis marked by record prices and market volatility. Key developments include Barry Callebaut signing a distribution agreement with Planet A Foods for cocoa-free ChoViva, Mondelēz and Celleste Bio producing the first cell-cultivated chocolate bars, and Nestlé launching the first permanent cocoa-free chocolate product, Choco Crossies Snack Vibes, in Germany targeting Gen Z consumers. Significant hurdles remain, including regulatory approval requirements for novel ingredients and concerns around demand and affordability before alternative cocoa can achieve mainstream adoption.FoodHack🏆 And the winner is...Kioga won the 2026 FoodTech World Cup at HackSummit, with its CEO citing a shift toward biology-first food solutions. The roundup also covers 48 AgriFoodTech unicorns, novel food approvals, and funding rounds, including Cosaic's $6M seed extension and Afresh's $34M raise.CTechIsraeli startup unveils world’s first chocolate bars made with lab-grown cocoa butterIsraeli food technology startup Celleste Bio announced it has produced the world's first chocolate bars using cocoa butter grown through cell suspension culture in a bioreactor, in collaboration with Mondelēz International. The company claims a single cocoa bean could generate up to one ton of cocoa butter annually in a 1,000-liter bioreactor, potentially replacing what would otherwise require about a hectare of cocoa trees. Celleste says its bio-identical cocoa butter delivers the same melt profile and texture as conventional cocoa butter and functions as a direct replacement in existing manufacturing processes, with the company targeting commercial-scale production within two years.Interesting EngineeringNew startup makes ‘world’s first’ lab-grown chocolate barsA food tech startup, Celleste Bio, has created lab-grown milk chocolate bars using cocoa butter produced via cell culture technology, with partner Mondelez International manufacturing prototypes. The process reduces land use, resources needed, and climate impact, and aims to scale commercially by 2027. The development addresses supply chain pressures from climate change and deforestation.PR NewswireCelleste Bio™ Unveils World's First Milk Chocolate Bars Made with Cell Cultured Cocoa ButterCelleste Bio unveiled the world's first milk chocolate bars made with cell cultured cocoa butter, produced in partnership with Mondelēz International, which used the butter to create nearly a dozen chocolate bars meeting its product standards. The milestone demonstrates that Celleste's cell cultured cocoa butter is bio-identical to conventionally sourced cocoa, delivering identical texture, melt profile, and sensory experience. The company is targeting commercial-scale production of 1 ton of cocoa butter annually in a 1,000-liter bioreactor from a single bean within the next two years.